title: Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient.
authors.affiliation: Division of Nephrology, The Chaim Sheba Medical Centre, Tel-Hashomer, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. m_bilu_k@netvision.net.il
authors.forename: Margarita
authors.initials: M
authors.lastname: Kunin
authors.forename: Juri
authors.initials: J
authors.lastname: Kopolovic
authors.forename: Abraham
authors.initials: A
authors.lastname: Avigdor
authors.forename: Eliezer J
authors.initials: EJ
authors.lastname: Holtzman
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001485:Basement Membrane / Q000473:pathology; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007678:Kidney Glomerulus / Q000473:pathology; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D000077268:Pamidronate
chemical_list: D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate